sur CureVac (NASDAQ:CVAC)
CureVac to Announce Q4 and Full-Year 2023 Results on April 24, 2024
CureVac N.V., a biopharmaceutical company specializing in mRNA-based therapies, is set to announce its fourth quarter and full-year 2023 financial results and business updates on April 24, 2024. The announcement will be accompanied by a conference call and webcast.
The event will occur at 3 p.m. CET, which translates to 9 a.m. EST, allowing global stakeholders to participate. Attendees can join the conference call using various dial-in numbers provided for U.S., international, and German participants. The webcast will be available on CureVac's website, with corresponding presentation slides to be uploaded shortly before the session begins. A replay of the webcast will also be provided on the website after the event concludes.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de CureVac